COVID-19. Covid-19
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: age equal or more than 18 years; The patient have written consciously and freely consent to participate in the study. Confirmed diagnosis of COVID-19, with Laboratory (RT-PCR) confirmation. Confirmed diagnosis of COVID-19, with lung CT-Scan result, which is typical for COVID-19 pulmonary involvement. The patient has clinical symptom of COVID-19 (dry cough, respiratory distress, fever) Less than 7 days have passed since the onset of symptoms;
Exclusion criteria
Exclusion criteria: The patient is in another clinical trial at the same time. The patient needs to receive medical care from the intensive care unit
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptoms (dry cough). Timepoint: Daily monitoring, but the result of baseline (before the initiation of intervention), and day 7 from the initiation, is recorded. Method of measurement: Physical examination,questionnaire.;Clinical symptoms (respiratory distress). Timepoint: Daily monitoring, but the result of baseline (before the initiation of intervention), and day 7 from the initiation, is recorded. Method of measurement: pulse oxymetery device.;Clinical symptoms (fever). Timepoint: Daily monitoring, but the result of baseline (before the initiation of intervention), and day 7 from the initiation, is recorded. Method of measurement: Thermometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Lab tests changes. Timepoint: daily monitoring, but the before the intervention initiation (baseline) and day 7 results will recorded on designed checklist. Method of measurement: blood sample, laboratory analysis. | — |
Countries
Iran (Islamic Republic of)
Contacts
Bagheiat-allah University of Medical Sciences